Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyndy B Cordell

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the American Medical Directors Association|October 5, 2015
How Should Cognitive Impairment Be Recognized?Keith N Fargo, Cyndy B Cordell, Maria C Carrillo
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2012
Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care settingCyndy B Cordell, Soo Borson, Malaz Boustani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 28, 2024
The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's diseaseRichard C Mohs, Douglas Beauregard, John Dwyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 28, 2026
Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease but without amyloid deposits on positron emission tomography: Results from Bio-Hermes Study participantsRichard C Mohs, Douglas W Beauregard, Lynne Hughes, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the American Medical Directors Association|October 5, 2015
How Should Cognitive Impairment Be Recognized?Keith N Fargo, Cyndy B Cordell, Maria C Carrillo
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2012
Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care settingCyndy B Cordell, Soo Borson, Malaz Boustani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 28, 2024
The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's diseaseRichard C Mohs, Douglas Beauregard, John Dwyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 28, 2026
Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease but without amyloid deposits on positron emission tomography: Results from Bio-Hermes Study participantsRichard C Mohs, Douglas W Beauregard, Lynne Hughes, et al.
Pageof 1